Cook Medical to Distribute Bentley’s BeBack Catheter in the United States

March 21, 2024—Cook Medical and Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced a United States distribution agreement for Bentley’s BeBack catheter. Cook Medical will assume commercial responsibilities for the BeBack device in the United States during the coming months.

According to the companies, BeBack is a crossing catheter designed for steering through chronic total occlusions (CTOs) that provides targeted reentry options. The catheter’s features include a steerable and adjustable nitinol needle, a radiopaque marker located near the tip of the catheter indicating the direction in which the needle curves, and 80- and 120-cm lengths and 2.9- and 4-F sizes.

“We are excited to welcome Bentley’s BeBack catheter to our peripheral intervention portfolio,” stated Alec Cerchiari, Director of Product Management for Cook’s Peripheral Artery Disease and Venous specialty.

Cerchiari continued, “The BeBack catheter is a unique tool for crossing heavily calcified lesions in antegrade or retrograde fashion. It complements Cook’s robust portfolio of above- and below-the-knee products, including our Micropuncture pedal introducer access sets, Flexor guiding sheaths, and CXI support catheter.”

Martijn Nugteren, Director of Sales and Marketing at Bentley, added, “The BeBack catheter is an effective approach for successful recanalization and should be available in every lab across the United States. Thanks to this collaboration with Cook, we will now have a better commercial footprint in the United States with even more opportunities to treat patients with debilitating arterial and venous disease.”

In May 2023, Bentley introduced the BeBack device. In addition to FDA clearance, the BeBack device has received CE Mark approval and was launched outside the United States in January 2023.